Raphael Mohr
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Liver Disease and Transplantation 12
- Hepatitis C virus research 8
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 12
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 19
- Neuroendocrine Tumor Research Advances 7
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
-
- Gallbladder and Bile Duct Disorders 8
Raphael Mohr
62 papers receiving 927 citations
Peers
Comparison fields: 5 of 77
- Hepatology 290
- Oncology 307
- Epidemiology 311
- Cancer Research 131
- Immunology 169
Countries citing papers authored by Raphael Mohr
This map shows the geographic impact of Raphael Mohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Mohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Mohr more than expected).
Fields of papers citing papers by Raphael Mohr
This network shows the impact of papers produced by Raphael Mohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Mohr. The network helps show where Raphael Mohr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raphael Mohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 35 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 7 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 22 | |
| 15 | 2021 | 34 | |
| 16 | 2021 | 21 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 4 | |
| 19 | 2020 | 10 | |
| 20 | 2020 | 8 |
About Raphael Mohr
Raphael Mohr is a scholar working on Hepatology, Oncology and Epidemiology, having authored 70 papers that have together received 942 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease and Transplantation (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Gallbladder and Bile Duct Disorders (8 papers), Hepatitis C virus research (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). The work is most often cited by research in Hepatology (290 citations), Oncology (307 citations) and Epidemiology (311 citations). Raphael Mohr has collaborated with scholars based in Germany, Spain and Denmark. Frequent co-authors include Frank Tacke, Christoph Roderburg, Jürgen K. Rockstroh, Ulrich Spengler, Christian P. Strassburg, Maria A. González-Carmona, Jonel Trebicka, Leona Dold, Annabelle Vogt and Tom Luedde. Their work appears in journals such as PLoS ONE, Cancers, Liver International, Journal of Clinical Medicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.